Novalar Gets Investment

San Diego-based Novalar, a firm developing local dental anesthetic reversal agents, has raised a round of venture funding, according to venture firm New Enterprise Associates. Financial terms of the investment were not disclosed. NEA said that the round was a Series D funding, and that it has added Michael Raab to Novalar's board. Novalar has previously raised funding from Boston Millenia Partners, Domain Associates, and Sears Capital Management; however, NEA did not disclose if those investors also participated in the funding. More information »